Breast cancer charity under fire for overstating the benefits of screening

August 2, 2012, British Medical Journal

Professors Lisa Schwartz and Steven Woloshin of the Center for Medicine and the Media at The Dartmouth Institute for Health Policy and Clinical Practice argue that last year's breast cancer awareness month campaign by Susan G Komen for the Cure "overstates the benefit of mammography and ignores harms altogether."

Their views are published on bmj.com today as part of an occasional series highlighting the exaggerations, distortions, and selective reporting that make some news stories, advertising, and medical journal articles "not so."

A growing and increasingly accepted body of evidence shows that although screening may reduce a woman's chance of dying from breast cancer by a small amount, it also causes major harms, say the authors. Yet Komen's public advertising campaign gives women no sense that screening is a close call.

Instead it states that the key to surviving breast cancer is for women to get screened because "early detection saves lives. The 5-year survival rate for breast cancer when caught early is 98%. When it's not? 23%."

This benefit of mammography looks so big that it is hard to imagine why any woman would forgo screening. But the authors explain that comparing survival between screened and unscreened women is "hopelessly biased."

For example, imagine a group of 100 women who received diagnoses of breast cancer because they felt a breast lump at age 67, all of whom die at age 70. Five year survival for this group is 0%. Now imagine the women were screened, given their diagnosis three years earlier, at age 64, but still die at age 70. Five year survival is now 100%, even though no one lived a second longer.

Overdiagnosis (the detection of cancers that will not kill or even cause symptoms during a patient's lifetime) also distorts survival statistics because the numbers now include people who have a diagnosis of cancer but who, by definition, survive the cancer, the authors add.

"If there were an Oscar for misleading statistics, using survival statistics to judge the benefit of screening would win a lifetime achievement award hands down," they write.

But that doesn't stop people from misinterpreting survival statistics. Disturbingly, in a recent survey, the authors found that most US primary care doctors also mistakenly interpret improved survival as evidence that screening saves lives.

Mammography certainly sounds better when stated in terms of improving five year survival - from 23% to 98%, a difference of 75 percentage points, they say. But in terms of its actual benefit, mammography can reduce the chance that a woman in her 50s will die from over the next 10 years from 0.53% to 0.46%, a difference of 0.07 percentage points.

The Komen advertisement also ignores the harms of screening, they add. For every life saved by mammography, around two to 10 women are overdiagnosed. These women cannot benefit from unnecessary chemotherapy, radiation, or surgery. All they do experience is harm.

"Women need much more than marketing slogans about screening: they need - and deserve - the facts," conclude the authors. "The Komen advertisement campaign failed to provide the facts. Worse, it undermined decision making by misusing statistics to generate false hope about the benefit of . That kind of behaviour is not very charitable."

Explore further: Study finds mammography beneficial for younger women

More information: www.bmj.com/cgi/doi/10.1136/bmj.e5132

Related Stories

Study finds mammography beneficial for younger women

April 26, 2012
Researchers from University Hospitals (UH) Case Medical Center and Case Western Reserve University School of Medicine have published new findings that mammography remains beneficial for women in their 40s. According to a ...

New study supports claim that breast screening may be causing more harm than good

December 9, 2011
A new study published on bmj.com today supports the claim that the introduction of breast cancer screening in the UK may have caused more harm than good.

Probability model estimates proportion of women who survive breast cancer detected through screening

October 24, 2011
A model used to estimate breast cancer survival rates found that the probability that a woman with screen-detected breast cancer will avoid a breast cancer death because of screening mammography may be lower than previously ...

Annual mammography with screening ultrasound may benefit women at increased risk of breast cancer

April 3, 2012
The addition of a screening ultrasound or magnetic resonance imaging (MRI) to annual mammography in women with an increased risk of breast cancer and dense breast tissue resulted in a higher rate of detection of incident ...

Recommended for you

Scientists zoom in to watch DNA code being read

January 17, 2018
Scientists have unveiled incredible images of how the DNA code is read and interpreted—revealing new detail about one of the fundamental processes of life.

T-cells engineered to outsmart tumors induce clinical responses in relapsed Hodgkin lymphoma

January 16, 2018
WASHINGTON-(Jan. 16, 2018)-Tumors have come up with ingenious strategies that enable them to evade detection and destruction by the immune system. So, a research team that includes Children's National Health System clinician-researchers ...

Researchers identify new treatment target for melanoma

January 16, 2018
Researchers in the Perelman School of Medicine at the University of Pennsylvania have identified a new therapeutic target for the treatment of melanoma. For decades, research has associated female sex and a history of previous ...

More evidence of link between severe gum disease and cancer risk

January 16, 2018
Data collected during a long-term health study provides additional evidence for a link between increased risk of cancer in individuals with advanced gum disease, according to a new collaborative study led by epidemiologists ...

Researchers develop a remote-controlled cancer immunotherapy system

January 15, 2018
A team of researchers has developed an ultrasound-based system that can non-invasively and remotely control genetic processes in live immune T cells so that they recognize and kill cancer cells.

Dietary fat, changes in fat metabolism may promote prostate cancer metastasis

January 15, 2018
Prostate tumors tend to be what scientists call "indolent" - so slow-growing and self-contained that many affected men die with prostate cancer, not of it. But for the percentage of men whose prostate tumors metastasize, ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

PeterD
not rated yet Aug 03, 2012
Komen has always been a fraud. The last thing they want is a cure for cancer; then the money train wold stop. In truth, most cancer is easily cured with proper nutrition, but Komen works hard to make sure you don't find that out.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.